Topics
-
Business Results Announcement for the Fiscal Year Ended March 31, 2022 (See Latest Financial Statements)
-
Sysmex Selected for Inclusion in the “FTSE Blossom Japan Sector Relative Index”
-
Sysmex Presents Academic Report in Effort to Create a Simple Blood Test to Diagnose Alzheimer’s Disease
-
Posted the 19th Technology Presentation
-
Implementing the Group-wide Unified Social Contribution Activity “Sysmex Gives Back Day”
-
Business Results Announcement for the First Nine Months of the Fiscal Year Ending March 31, 2022 (See Latest Financial Statements)
Press Releases
- Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
- Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2022 (PDF：169KB)
- Announcement of Executive Change (PDF：150KB)
-
Declaration of Achieving Carbon Neutrality by 2040
- Contributing to the Realization of a Sustainable Society Through Initiatives to Deal with Climate Change - -
Astrego Diagnostics AB Becomes Wholly-owned Sysmex Subsidiary through the Acquisition of Outstanding Shares
- Commercialization of Rapid Antimicrobial Susceptibility Test to Reinforce Structure for Promoting AMR Countermeasures - (PDF：188KB)
